1793 related articles for article (PubMed ID: 10370639)
1. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
Griga T; Hebler U; Voigt E; Tromm A; May B
Hepatogastroenterology; 2000; 47(36):1604-7. PubMed ID: 11149012
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
5. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
6. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
7. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
8. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease.
Beddy D; Watson RW; Fitzpatrick JM; O'Connell PR
Br J Surg; 2004 Jan; 91(1):72-7. PubMed ID: 14716797
[TBL] [Abstract][Full Text] [Related]
9. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
[TBL] [Abstract][Full Text] [Related]
10. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
[TBL] [Abstract][Full Text] [Related]
12. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
13. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease.
Konno S; Iizuka M; Yukawa M; Sasaki K; Sato A; Horie Y; Nanjo H; Fukushima T; Watanabe S
J Gastroenterol; 2004 Oct; 39(10):931-9. PubMed ID: 15549445
[TBL] [Abstract][Full Text] [Related]
15. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
[TBL] [Abstract][Full Text] [Related]
16. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
Schmitz-Moormann P; Himmelmann GW; Brandes JW
Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of pancreatitis associated protein in inflammatory bowel disease.
Gironella M; Iovanna JL; Sans M; Gil F; Peñalva M; Closa D; Miquel R; Piqué JM; Panés J
Gut; 2005 Sep; 54(9):1244-53. PubMed ID: 15870231
[TBL] [Abstract][Full Text] [Related]
18. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
19. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
Griga T; Gutzeit A; Sommerkamp C; May B
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):175-9. PubMed ID: 10102229
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of Crohn's disease of the colon from ulcerative colitis: ultrastructure study with the scanning electron microscope.
Trabucchi E; Mukenge S; Baratti C; Colombo R; Fregoni F; Montorsi W
Int J Tissue React; 1986; 8(1):79-84. PubMed ID: 3949447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
